Results 11 to 20 of about 2,535,326 (289)

Investigating the impact of NHS based ovarian cancer screening [PDF]

open access: yes, 2010
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core   +7 more sources

Ovarian Diseases

open access: yes, 2017
Patient Education Library: Ovarian Diseases.
Massengill, Jason C.
core   +4 more sources

Investigating the potential for expediting diagnosis of ovarian cancer via prompt symptom recognition & "targeted screening" [PDF]

open access: yes, 2009
PhDThis thesis explores the potential for using symptoms as a tool to bring forward the diagnosis of ovarian cancer. Current evidence supports the existence of prediagnostic symptoms, however symptom lead time has yet to be adequately quantified ...
Lim, Anita Wey Wey
core   +4 more sources

Performance of Ovarian Response Prediction Index As Predictor of Ovarian Response

open access: yesCentral Asian Journal of Medical Sciences, 2022
Objective: We aimed to evaluate potential predictors of response to controlled ovarian stimulation (COS), including follicle stimulating hormone (FSH), Estradiol, antral follicle count (AFC), and ovarian response prediction index (ORPI). Methods: In this
Bolormaa Dagvadorj   +5 more
doaj   +1 more source

Ovarian Biomechanics: From Health to Disease

open access: yesFrontiers in Oncology, 2022
Biomechanics is a physical phenomenon which mainly related with deformation and movement of life forms. As a mechanical signal, it participates in the growth and development of many tissues and organs, including ovary.
Chenchen Sun   +4 more
doaj   +1 more source

RUNX1-Regulated Signaling Pathways in Ovarian Cancer

open access: yesBiomedicines, 2023
Ovarian cancer is the leading cause of gynecological death worldwide, and its poor prognosis and high mortality seriously affect the life of ovarian cancer patients.
Yuanzhi Chen, Yingying He, Shubai Liu
doaj   +1 more source

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

open access: yesFrontiers in Pharmacology, 2019
Objective: Apolipoprotein A1 (ApoA1) is remarkably decreased in serum and ovarian tissues of ovarian cancer patients. ApoA1 and ApoA1 mimetic peptides can sequestrate pro-inflammatory phospholipids, some of which are known to activate a variety of ...
Aline T. Marinho   +8 more
doaj   +1 more source

Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]

open access: yes, 2012
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Kirschenhofer, Angela   +9 more
core   +1 more source

Paraneoplastic thrombocytosis in ovarian cancer [PDF]

open access: yes, 2012
<p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D.   +33 more
core   +1 more source

Polyamines in Ovarian Aging and Disease

open access: yesInternational Journal of Molecular Sciences, 2023
Ovarian aging and disease-related decline in fertility are challenging medical and economic issues with an increasing prevalence. Polyamines are a class of polycationic alkylamines widely distributed in mammals. They are small molecules essential for cell growth and development.
Bo Kang   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy